SEC Form 4 · accession 0001437749-18-010594
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arlene Morris
Director
Period of report
May 22, 2018
Accepted (ET)
May 23, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Purchase)F1 | $1.75 | May 22, 2018 | A | 17,500 | A | — | May 21, 2028 | Common Stock | 17,500 | 17,500 | D |
Explanation of responses
- F1The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received 17,500 non-qualified stock options on May 22, 2018 (the "Grant Date"). The non-qualified stock options shall vest in full on the first anniversary of the Grant Date.